New Findings From Global Survey Of Women Living With Metastatic Breast Cancer Highlig
 

Newly released findings from the BRIDGE survey (Bridging Gaps, Expanding Outreach - Metastatic Breast Cancer Patient Survey) found that most (78 percent) women living with metastatic breast cancer (MBC) have never participated in a clinical trial. Of these women, more than half (56 percent) were never invited to consider a clinical trial and one-third (30 percent) had not been recommended a clinical trial by their healthcare provider.

More...